Many clinical trials of new cancer drugs may be inappropriately excluding some people with “Duffy-null phenotype,” a trait found predominantly in people of African or Middle Eastern descent, researchers at Dana-Farber Cancer Institute and Queen Mary University of London report in a new study.
Expert Guide to Oral Solid Dosage Manufacturing Companies & Equipment
Oral solid dosage manufacturing companies, equipment and market: Introduction In an industry where precision and compliance are of paramount importance, selecting the right partner for
May 10, 2024